Using data science to improve healthcare outcomes, the Swiss AI platform PeakData has raised €12.1 million in Series A funding to identify and collate the most relevant and impactful healthcare professionals for pharmaceutical companies.
As the COVID-19 pandemic has shown, it is critical for pharmaceutical companies to find and engage digital activators to reach more healthcare professionals, earlier and quicker.
This can steepen the product adoption curve.
The round was led by AlbionVC and backed by Octopus Ventures and Heal Capital.
According to the company, the Series A funding follows rapid 6x growth over 2021, with the PeakData platform now being used by over half of Europe’s largest pharmaceutical companies.
Founded in 2018 by Patrick De Boer and Michael Feldman, the platform uses AI algorithms to rank Healthcare professionals in terms of their digital impact, influence, and relevance to their target market.
It uses dynamic data to observe changes in Healthcare professionals’ status over time.
Thus, the startup enables pharmaceutical companies to enhance the depth and breadth of their customer base and learn more about Healthcare professionals that are most relevant to their target market.
This, in turn, enables patients to benefit from innovative new medicines much sooner.
Read more on Tech Gist Africa:
Switzerland-based Bcomp closes $35 million round
